Mark M. Jones

6.9k total citations · 3 hit papers
193 papers, 4.9k citations indexed

About

Mark M. Jones is a scholar working on Health, Toxicology and Mutagenesis, Nutrition and Dietetics and Organic Chemistry. According to data from OpenAlex, Mark M. Jones has authored 193 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Health, Toxicology and Mutagenesis, 39 papers in Nutrition and Dietetics and 28 papers in Organic Chemistry. Recurrent topics in Mark M. Jones's work include Heavy Metal Exposure and Toxicity (53 papers), Trace Elements in Health (39 papers) and Acute Myeloid Leukemia Research (16 papers). Mark M. Jones is often cited by papers focused on Heavy Metal Exposure and Toxicity (53 papers), Trace Elements in Health (39 papers) and Acute Myeloid Leukemia Research (16 papers). Mark M. Jones collaborates with scholars based in United States, United Kingdom and France. Mark M. Jones's co-authors include James Blair, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, Karina S. Blair, Claire Harrison, Mark A. Basinger, Alayne B. Smith, Shirley G. Jones, Glen R. Gale and Pramod K. Singh and has published in prestigious journals such as New England Journal of Medicine, Journal of the American Chemical Society and Journal of Clinical Oncology.

In The Last Decade

Mark M. Jones

185 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study

2019 703 citations Georgina V. Long, Reinhard Dummer et al. The Lancet Oncology profile →
Ruxolitinib versus Standard Therapy for the Treatment of Polycythemia Vera

2015 594 citations Alessandro M. Vannucchi, Jean‐Jacques Kiladjian et al. profile →
Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis

2016 350 citations Claire Harrison, Alessandro M. Vannucchi et al. Leukemia profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark M. Jones United States	31	1.0k	917	910	769	756	193	4.9k
Roberta J. Ward United Kingdom	47	669 0.7×	1.7k 1.9×	361 0.4×	1.3k 1.7×	499 0.7×	174	7.6k
John A. Lawson United States	65	242 0.2×	3.3k 3.6×	688 0.8×	408 0.5×	180 0.2×	250	15.4k
Anthony R. White Australia	56	366 0.4×	4.0k 4.3×	1.1k 1.3×	143 0.2×	1.2k 1.5×	205	10.7k
Gareth Williams United Kingdom	53	237 0.2×	3.5k 3.8×	1.2k 1.3×	116 0.2×	58 0.1×	272	10.0k
Paul R. Lockman United States	43	793 0.8×	2.6k 2.9×	1.5k 1.6×	129 0.2×	189 0.3×	115	7.0k
Dominic J. Hare Australia	48	187 0.2×	1.5k 1.7×	216 0.2×	422 0.5×	1.2k 1.6×	128	7.1k
Joseph M. Rifkind United States	43	590 0.6×	2.0k 2.2×	278 0.3×	398 0.5×	200 0.3×	136	5.8k
Quentin R. Smith United States	43	869 0.9×	2.1k 2.2×	2.2k 2.4×	69 0.1×	155 0.2×	105	6.9k
Richard A. Cohen United States	77	183 0.2×	8.1k 8.8×	552 0.6×	166 0.2×	244 0.3×	305	22.1k
Thomas A. Kent United States	49	194 0.2×	2.3k 2.5×	345 0.4×	131 0.2×	66 0.1×	201	9.7k

Countries citing papers authored by Mark M. Jones

Since Specialization

Citations

This map shows the geographic impact of Mark M. Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark M. Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark M. Jones more than expected).

Fields of papers citing papers by Mark M. Jones

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark M. Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark M. Jones. The network helps show where Mark M. Jones may publish in the future.

Co-authorship network of co-authors of Mark M. Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Mark M. Jones. A scholar is included among the top collaborators of Mark M. Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark M. Jones. Mark M. Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Iersel, Leo van, et al.. (2025). A simple 4-approximation algorithm for maximum agreement forests on multiple unrooted binary trees. Information Processing Letters. 190. 106572–106572.

Jones, Mark M., et al.. (2023). A tailored physical education program enhances elementary students' self‐efficacy, attitudes, and motivation to engage in physical activity. Psychology in the Schools. 60(9). 3419–3434. 4 indexed citations

Jones, Mark M., et al.. (2022). Engaging with Maths Online - teaching mathematics collaboratively and inclusively through a pandemic and beyond. MSOR Connections. 20(1). 74–83. 4 indexed citations

Jones, Mark M., et al.. (2020). Programming in Groups: developing industry-facing software development skills in the undergraduate mathematics curriculum. MSOR Connections. 18(2). 18–24. 3 indexed citations

Jones, Mark M., et al.. (2019). Thematic problem solving: a case study on an approach to teaching problem solving in undergraduate mathematics. MSOR Connections. 17(2). 54–59. 2 indexed citations

Long, Georgina V., Reinhard Dummer, Omid Hamid, et al.. (2019). Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma (ECHO-301/KEYNOTE-252): a phase 3, randomised, double-blind study. The Lancet Oncology. 20(8). 1083–1097. 703 indexed citations breakdown →

Harrison, Claire, Alessandro M. Vannucchi, Jean‐Jacques Kiladjian, et al.. (2016). Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis. Leukemia. 30(8). 1701–1707. 350 indexed citations breakdown →

Thomas, Xavier, et al.. (2013). A Post Hoc Sensitivity Analysis of Survival Probabilities in a Multinational Phase III Trial of Decitabine in Older Patients With Newly Diagnosed Acute Myeloid Leukemia. Clinical Lymphoma Myeloma & Leukemia. 14(1). 68–72. 17 indexed citations

Blair, Karina S., Bruce W. Smith, Rebecca Rhodes, et al.. (2008). Response to Emotional Expressions in Generalized Social Phobia and Generalized Anxiety Disorder: Evidence for Separate Disorders. American Journal of Psychiatry. 165(9). 1193–1202. 215 indexed citations

10.

Blair, Karina S., Marilla Geraci, Jeffrey DeVido, et al.. (2008). Neural Response to Self- and Other Referential Praise and Criticism in Generalized Social Phobia. Archives of General Psychiatry. 65(10). 1176–1176. 132 indexed citations

11.

Jones, Mark M.. (2001). Bounded Composition Operators on Weighted Bergman Spaces. Journal of Mathematical Analysis and Applications. 256(2). 650–667. 1 indexed citations

12.

Ryan, Michael P., et al.. (1995). The Role of the Renin-Angiotensin System in Cisplatin Nephrotoxicity. Renal Failure. 17(6). 665–674. 29 indexed citations

13.

Kostial, Krista, et al.. (1995). Monoisoamyl and mono‐n‐hexyl meso‐2,3‐dimercaptosuccinate in mobilizing ²⁰³hg retention in relation to age of rats and route of administration. Journal of Applied Toxicology. 15(3). 201–206. 10 indexed citations

14.

Jones, Mark M., Mark A. Basinger, Glen R. Gale, et al.. (1994). Effect of chelate treatments on kidney, bone and brain lead levels of lead-intoxicated mice. Toxicology. 89(2). 91–100. 33 indexed citations

15.

Jones, Mark M.. (1992). Effect of dithiocarbamates and dithiocarbamate-induced cadmium mobilization on essential trace metal metabolism in the female rat. Fundamental and Applied Toxicology. 19(3). 432–437. 6 indexed citations

16.

Jones, Mark M., Pramod K. Singh, Shirley G. Jones, & Myron A. Holscher. (1991). Dithiocarbamates of Improved Efficacy for the Mobilization of Retained Cadmium from Renal and Hepatic Deposits. Pharmacology & Toxicology. 68(2). 115–120. 8 indexed citations

17.

Jones, Mark M., Glen R. Gale, Pramod Kumar Singh, & Alayne B. Smith. (1989). The rate of the in vivo dithiocarbamate-induced mobilization of hepatic and renal cadmium deposits. Toxicology. 58(3). 313–323. 2 indexed citations

18.

Jones, Mark M.. (1985). Heavy-Metal Detoxification Using Sulfur Compounds. Sulfur Reports. 4(4). 119–150. 5 indexed citations

19.

Jones, Mark M.. (1976). Chemistry, man, and society. Saunders eBooks.

20.

Jones, Mark M.. (1968). Ligand reactivity and catalysis. Academic Press eBooks. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact